VA awards $160.9M for kidney dialysis centers, with Fresenius Medical Care as the sole provider

Contract Overview

Contract Amount: $160,945,352 ($160.9M)

Contractor: Fresenius Medical Care Holdings Inc

Awarding Agency: Department of Veterans Affairs

Start Date: 2025-11-01

End Date: 2025-11-30

Contract Duration: 29 days

Daily Burn Rate: $5.5M/day

Competition Type: NOT COMPETED

Pricing Type: FIRM FIXED PRICE

Sector: Healthcare

Official Description: EXPRESS REPORT: FY 26 NOVEMBER NDSC EXPRESS REPORT

Place of Performance

Location: WALTHAM, MIDDLESEX County, MASSACHUSETTS, 02451

State: Massachusetts Government Spending

Plain-Language Summary

Department of Veterans Affairs obligated $160.9 million to FRESENIUS MEDICAL CARE HOLDINGS INC for work described as: EXPRESS REPORT: FY 26 NOVEMBER NDSC EXPRESS REPORT Key points: 1. The contract's value represents a significant investment in essential healthcare services for veterans. 2. Limited competition raises questions about potential price inflation and the availability of alternative providers. 3. The firm-fixed-price structure aims to control costs, but the absence of competition may undermine this. 4. Performance will be crucial in ensuring quality care for veterans requiring dialysis. 5. This contract falls within the broader healthcare sector, specifically focusing on specialized medical services. 6. The duration of the contract is relatively short, suggesting potential for future re-competition or adjustments.

Value Assessment

Rating: fair

The awarded amount of $160.9 million for kidney dialysis centers is substantial. Without specific benchmarks for comparable contracts or detailed cost breakdowns, it is difficult to definitively assess value for money. However, the sole-source nature of this award warrants scrutiny regarding whether the pricing reflects competitive market rates or if it is inflated due to a lack of bidding.

Cost Per Unit: N/A

Competition Analysis

Competition Level: sole-source

This contract was awarded on a sole-source basis, meaning only one vendor, Fresenius Medical Care Holdings Inc., was considered. This significantly limits the opportunity for price discovery and potentially leads to higher costs for the government compared to a fully competed contract. The rationale for this sole-source award needs to be clearly justified to ensure it serves the best interests of the VA and its beneficiaries.

Taxpayer Impact: The lack of competition means taxpayers may be paying a premium for these essential dialysis services. Without competitive pressure, there is less incentive for the contractor to offer the most cost-effective solution.

Public Impact

Veterans requiring kidney dialysis services will benefit directly from this contract, ensuring continuity of care. The contract provides essential medical services, specifically kidney dialysis, to a critical patient population. The geographic impact is primarily focused on areas served by the Department of Veterans Affairs facilities where these services are delivered. This contract supports healthcare professionals and ancillary staff involved in providing dialysis treatment.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Sole-source award limits competitive pricing and potentially increases costs for taxpayers.
Lack of competition may reduce the incentive for the contractor to innovate or improve service efficiency.
Dependence on a single provider could create risks if the contractor faces operational issues or performance declines.

Positive Signals

Firm-fixed-price contract provides cost certainty for the awarded period.
Contract ensures continued access to essential healthcare services for veterans.
The contractor, Fresenius Medical Care, is a known entity in the healthcare sector, potentially indicating established expertise.

Sector Analysis

The healthcare sector, particularly specialized medical services like dialysis, is a critical area of federal spending. This contract for kidney dialysis centers fits within the broader landscape of healthcare procurement aimed at serving specific patient populations. Benchmarking this contract against other federal or private sector dialysis service agreements would provide further context on its cost-effectiveness and market positioning.

Small Business Impact

The provided data does not indicate any small business set-aside provisions or subcontracting requirements for this contract. Therefore, the direct impact on the small business ecosystem appears minimal, and there is no explicit mechanism for small business participation or benefit.

Oversight & Accountability

Oversight for this contract would typically fall under the Department of Veterans Affairs' contracting and program management offices. Accountability measures would be tied to the performance standards outlined in the contract. Transparency regarding the justification for the sole-source award and ongoing performance monitoring is crucial for public trust.

Related Government Programs

Department of Veterans Affairs Medical Services
Federal Healthcare Contracts
End-Stage Renal Disease (ESRD) Treatment Programs

Risk Flags

Sole-source award
Potential for uncompetitive pricing
Limited transparency in vendor selection

Frequently Asked Questions

What is this federal contract paying for?

Department of Veterans Affairs awarded $160.9 million to FRESENIUS MEDICAL CARE HOLDINGS INC. EXPRESS REPORT: FY 26 NOVEMBER NDSC EXPRESS REPORT

Who is the contractor on this award?

The obligated recipient is FRESENIUS MEDICAL CARE HOLDINGS INC.

Which agency awarded this contract?

Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).

What is the total obligated amount?

The obligated amount is $160.9 million.

What is the period of performance?

Start: 2025-11-01. End: 2025-11-30.

What is the historical spending pattern for kidney dialysis services by the Department of Veterans Affairs?

Analyzing historical spending on kidney dialysis services by the VA is crucial for understanding trends and identifying potential cost efficiencies or escalations. Without specific historical data for this exact contract or service category, a general review of VA healthcare expenditures would be necessary. Typically, federal agencies track spending by service codes (like NAICS 621492 for Kidney Dialysis Centers) and by contractor over multiple fiscal years. This allows for the identification of consistent providers, fluctuations in service demand, and the overall budget allocated to such critical medical treatments. Examining past contract awards, their values, durations, and competition levels can reveal whether this $160.9 million award represents a significant increase, a continuation of established spending, or a deviation from prior patterns. It also helps in assessing if the VA has historically relied on sole-source providers for these services or if competitive bidding has been the norm.

How does the pricing of this contract compare to similar kidney dialysis services procured by other federal agencies or large healthcare systems?

Benchmarking the pricing of this $160.9 million contract against similar kidney dialysis services is essential for evaluating value for money. This comparison should ideally include contracts awarded by other federal agencies (like the Department of Defense or Health and Human Services) or even large civilian healthcare networks. Key metrics for comparison would include cost per dialysis session, cost per patient per month, or overall contract value relative to patient volume and service scope. Given that this is a sole-source award to Fresenius Medical Care Holdings Inc., a critical aspect of the comparison would be to ascertain if the negotiated rates are competitive with what Fresenius or other dialysis providers charge under competitive contracts elsewhere. A significant deviation from market rates, especially in the absence of unique contract requirements, could indicate potential overpricing.

What are the specific performance metrics and quality indicators included in this contract, and how will they be monitored?

The effectiveness and value of this $160.9 million contract hinge on the specific performance metrics and quality indicators established within its terms. These metrics should align with industry best practices for kidney dialysis and address critical aspects such as patient outcomes (e.g., mortality rates, complication rates), service timeliness, patient satisfaction, and adherence to clinical protocols. The contract should clearly define how these metrics will be measured, reported, and evaluated. Robust monitoring mechanisms, including regular performance reviews, site visits, and data analysis, are necessary to ensure the contractor, Fresenius Medical Care Holdings Inc., is meeting or exceeding expectations. The Department of Veterans Affairs' oversight team will be responsible for tracking these indicators and taking corrective action if performance falls short, thereby safeguarding the quality of care for veterans.

What is the justification for awarding this contract on a sole-source basis, and what risks does this present?

The justification for awarding this $160.9 million kidney dialysis contract on a sole-source basis to Fresenius Medical Care Holdings Inc. is a critical point of analysis. Sole-source awards are typically reserved for situations where only one responsible source can provide the required supplies or services, often due to unique capabilities, urgent needs, or specific circumstances. Without a competitive process, there is an inherent risk of inflated pricing, reduced innovation, and a lack of accountability driven by market forces. The VA must have a compelling justification, such as a documented lack of other qualified providers or a critical, time-sensitive need that precludes a full competition. The risks include potentially paying more than necessary, receiving suboptimal service levels if the contractor faces no competitive pressure, and facing challenges if the sole provider encounters operational difficulties.

What is Fresenius Medical Care Holdings Inc.'s track record with the Department of Veterans Affairs and other federal agencies?

Evaluating Fresenius Medical Care Holdings Inc.'s track record with the Department of Veterans Affairs (VA) and other federal agencies is vital for assessing the reliability and performance associated with this $160.9 million contract. This involves reviewing past contract performance evaluations (e.g., Contractor Performance Assessment Reporting System - CPARS), any history of disputes, litigation, or significant performance issues. Understanding their experience in delivering similar healthcare services, particularly dialysis, to government entities provides insight into their capabilities, responsiveness, and ability to meet federal requirements. A positive track record suggests a lower risk of performance failure, while a history of issues may warrant closer scrutiny and more stringent oversight for this current award.

Industry Classification

NAICS: Health Care and Social Assistance › Outpatient Care Centers › Kidney Dialysis Centers

Product/Service Code: MEDICAL SERVICES › OTHER MEDICAL SERVICES

Competition & Pricing

Extent Competed: NOT COMPETED

Solicitation Procedures: ONLY ONE SOURCE

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Parent Company: Bio-Medical Applications of Missouri, Inc.

Address: 920 WINTER ST, WALTHAM, MA, 02451

Business Categories: Category Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $160,945,352

Exercised Options: $160,945,352

Current Obligation: $160,945,352

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES

Cost or Pricing Data: NO

Parent Contract

Parent Award PIID: 36C10G24D0088

IDV Type: IDC

Timeline